AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernstrom, J. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernstrom, J. D
Agricola
Right arrow Articles by Fernstrom, J. D
American Journal of Clinical Nutrition, Vol. 71, No. 6, 1669S-1673s, June 2000
© 2000 American Society for Clinical Nutrition


Article

Can nutrient supplements modify brain function?1,2,3

John D Fernstrom

1 From the University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, Pittsburgh.

Over the past 40 y, several lines of investigation have shown that the chemistry and function of both the developing and the mature brain are influenced by diet. Examples are the effect of folate deficiency on neural tube development during early gestation, the influence of essential fatty acid deficiency during gestation and postnatal life on the development of visual function in infants, and the effects of tryptophan or tyrosine intake (alone or as a constituent of dietary protein) on the production of the brain neurotransmitters derived from them (serotonin and the catecholamines, respectively). Sometimes the functional effects are clear and the underlying biochemical mechanisms are not (as with folate and essential fatty acids); in other cases (such as the amino acids tyrosine and tryptophan), the biochemical effects are well understood, whereas the effect on brain function is not. Despite the incomplete knowledge base on the effects of such nutrients, investigators, physicians, and regulatory bodies have promoted the use of these nutrients in the treatment of disease. Typically, these nutrients have been given in doses above those believed to be required for normal health; after they have been given in pure form, unanticipated adverse effects have occasionally occurred. If this pharmacologic practice is to continue, it is important from a public safety standpoint that each nutrient be examined for potential toxicities so that appropriate purity standards can be developed and the risks weighed against the benefits when considering their use.

Key Words: Polyunsaturated fatty acid • PUFA • folic acid • tyrosine • tryptophan • choline • brain • brain development • affective disorders • Parkinson disease • Alzheimer disease • dietary supplements




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
I. Bjelland, G. S. Tell, S. E. Vollset, H. Refsum, and P. M. Ueland
Folate, Vitamin B12, Homocysteine, and the MTHFR 677C->T Polymorphism in Anxiety and Depression: The Hordaland Homocysteine Study
Arch Gen Psychiatry, June 1, 2003; 60(6): 618 - 626.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. M. Bier
Amino Acid Pharmacokinetics and Safety Assessment
J. Nutr., June 1, 2003; 133(6): 2034S - 2039.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
N. W Solomons
Ross Conference had too narrow a representation to speak about matters of the world
Am. J. Clinical Nutrition, March 1, 2001; 73(3): 654 - 655.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by The American Society for Nutrition